Vancomycin-resistant enterococci in Singaporean hospitals: 5-year results of a multi-centre surveillance programme

Annals of the Academy of Medicine Singapore

Volumn 41, Issue 2, 2012, Pages 77-81

  Cai, Yiying ^a   Chan, Joey P J ^b   Fisher, Dale Andrew ^c   Hsu, Li Yang ^c   Koh, Tse Hsien ^a   Krishnan, Prabha ^d   Kwa, Andrea L H ^a   Tan, Thean Yen ^e   Tee, Nancy W S ^f  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b KHOO TECK PUAT HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e CHANGI GENERAL HOSPITAL   (Singapore)

^f KK Hospital   (Singapore)

Author keywords

Antimicrobial resistance; Endemics; Passive surveillance; Vancomycin resistant enterococci

Indexed keywords

VANCOMYCIN;

ARTICLE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; ENTEROCOCCAL INFECTION; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INCIDENCE; MULTICENTER STUDY; PREVALENCE; SCREENING; SINGAPORE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84857962867     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
3. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686-707.
4. Infectious Diseases Society of America. Bad bugs no drugs: as antibiotic discovery stagnates, a public health crisis brews. July 2004. Available at: http://idsociety.org/10x20.htm. Accessed 20 March 2011.
5. Chlebicki MP, Ling ML, Koh TH, Hsu LY, Tan BH, How KB, et al. First outbreak of colonization and infection with vancomycin-resistant Enterococcus faecium in a tertiary care hospital in Singapore. Infect Control Hosp Epidemiol 2006;27:991-3.
6. Kurup A, Chlebicki MP, Ling ML, Koh TH, Tan KY, Lee LC, et al. Control of a hospital-wide vancomycin-resistant enterococci outbreak. Am J Infect Control 2008;36:206-11.
7. Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline, 2nd ed. Document M39-A2, vol. 25, no. 28. 2006. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Wood AJ. Vancomycin resistant enterococcal infections. N Engl J Med 2000;342:710-21.
9. Perichon B, Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53:4580-7.
10. Tschudin Sutter S, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF. Not all patients with vancomycin-resistant enterococci need to be isolated. Clin Infect Dis 2010;51:678-83.
11. Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009;30:184-6.
12. Koh TH, Low BS, Leo N, Hsu LY, Lin RT, Krishnan P, et al. Molecular epidemiology of vancomycin-resistant enterococci in Singapore. Pathology 2009;41:676-80.
13. Hsu LY, Tan TY, Jureen R, Koh TH, Krishnan P, Tzer-Pin Lin R, et al. Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 2007;13:1944-7.
14. Pereira LA, Fisher DA. Methicillin-resistant Staphylococcus aureus control in Singapore: moving forward. Ann Acad Med Singapore 2008;37:891-6.